Caitong International Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$841K Buy
2,174
+1,713
+372% +$635K 0.12% 151
2026
Q1
$135K Buy
+461
New +$152K 0.02% 498
2025
Q4
Sell
-209
Closed -$67.5K 2024
2025
Q3
$67.5K Buy
209
+29
+16% +$9.02K 0.05% 246
2025
Q2
$70K Buy
+180
New +$72.4K 0.05% 202
2025
Q1
Sell
-197
Closed -$72.7K 2262
2024
Q4
$72.7K Buy
+197
New +$82.4K 0.07% 336

Other funds holding ELV

Caitong International Asset Management's ELV Position: Q2 2026 in Review

Caitong International Asset Management increased its Elevance Health (ELV) stake by 372% in Q2 2026, buying an estimated $635K and bringing the position to 2,174 shares worth $841K. The position accounts for 0.12% of the portfolio, ranked #151.

Caitong International Asset Management first reported a position in ELV in Q4 2024 and has held it in 5 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Caitong International Asset Management held 2,174 shares of Elevance Health worth $841K as of Q2 2026.
  • Caitong International Asset Management bought 1,713 Elevance Health shares in Q2 2026, an estimated $635K.
  • Elevance Health made up 0.12% of Caitong International Asset Management's portfolio in Q2 2026, its #151 holding.
  • Caitong International Asset Management first reported a position in Elevance Health in Q4 2024 and has held it in 5 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.